Masport® is a trusted botulinum toxin type A product with proven efficacy and safety. With over 12 years of market presence and more than 6 million injections administered annually, Masport® offers healthcare professionals a reliable solution for both cosmetic and therapeutic applications.
Years in Market
Injections per Year
Vials Sold Annually
Days Efficacy Duration
Masport® is indicated for both cosmetic and therapeutic applications, providing healthcare professionals with versatile treatment options.
Treatment of glabellar lines, crow's feet, and facial wrinkles for aesthetic enhancement.
Learn MoreTherapeutic application for managing overactive bladder symptoms in adult patients.
Learn MoreTreatment of cervical dystonia to reduce abnormal head position and neck pain.
Learn MoreTreatment of severe axillary hyperhidrosis (excessive underarm sweating).
Learn MoreManagement of upper and lower limb spasticity in adult patients, including post-stroke spasticity.
Learn MoreAvailable in three unit strengths to meet various clinical needs
Our flagship product - ideal for larger treatment areas and multiple injection sites. Most popular choice for comprehensive treatments.
Versatile mid-range option suitable for moderate treatment areas and standard therapeutic applications.
Perfect for smaller treatment areas and targeted cosmetic applications requiring precise dosing.
Lyophilized
150, 300, 500 Units
2-8°C
A Phase III Clinical Study of the Efficacy and Safety of Botulinum Toxin Type A (MASPORT) with DYSPORT for the Treatment of Glabellar Lines.
Conclusion: Masport is as safe and effective as Dysport for glabellar lines, with comparable efficacy and duration up to 180 days.
| Product | Rate at Maximal Frown (Day 30) | Rate at Rest | Subject Self-Assessment |
|---|---|---|---|
| Masport® | 95.5% | 85.45% | 95.28% |
| Dysport® | 94.5% | 85.68% | 96.04% |
DOI: 10.1007/s00266-023-03766-5
View All Clinical EvidenceContact us today to learn more about Masport® and request pricing information for your clinic or practice.
Request a Quote Learn More